Mingyan Chu

Mingyan Chu is an accomplished Principal Scientist at US Pharmacopeia since April 2016, serving as the Expert Committee Scientific Lead and Scientific Liaison, overseeing the development of General Chapters for the USP-NF by evaluating supporting data and ensuring adherence to USP editorial standards. Previous experience includes roles in Technical Service at Sandoz, Analytical Method Development at Boehringer Ingelheim, Research and Development Scientist at Akorn, Inc., and Product Development Chemist at Apotex Inc. Mingyan Chu holds a Master's degree in Chemistry from Queen's University and two degrees from China Pharmaceutical University, including an M.Sc. in Pharmacy and a B.Sc. in Pharmacy.